Telix Pharmaceuticals (NASDAQ: TLX) is owned by 0.00% institutional shareholders, 0.00% Telix Pharmaceuticals insiders, and 100.00% retail investors. Ubs Group Ag is the largest individual Telix Pharmaceuticals shareholder, owning 3730.00 shares representing 0.00% of the company. Ubs Group Ag's Telix Pharmaceuticals shares are currently valued at $64.75k.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.